DXCM · NASDAQ
DexCom (DXCM) Stock Price & Fundamentals
DexCom (DXCM) closed at $626.14 on Oct 9, 2026, up 0.08% from the previous close of $625.67.
Share price, past year
1Y +4.23%Monthly closing prices
| Date | Close |
|---|---|
| Oct 9, 2026 | $626.14 |
| Sep 30, 2026 | $635.14 |
| Aug 31, 2026 | $616.84 |
| Jul 31, 2026 | $615.34 |
| Jun 30, 2026 | $612.40 |
| May 29, 2026 | $640.26 |
| Apr 30, 2026 | $617.51 |
| Mar 31, 2026 | $596.37 |
| Feb 27, 2026 | $569.36 |
| Jan 30, 2026 | $538.55 |
| Dec 31, 2025 | $575.90 |
| Nov 28, 2025 | $630.38 |
| Oct 31, 2025 | $604.73 |
Key statistics
- Market cap
- $236.31B
- P/E (TTM)
- 248.5
- EPS (TTM)
- $2.52
- Revenue (TTM)
- $4.97B
- Net income (TTM)
- $999.70M
- Shares outstanding
- 377.4M
- Dividend yield
- —
- 52-week range
- $538.55 – $653.59
DexCom's market cap is $236.31B, based on a share price of $626.14 and 377.4M shares outstanding as of Jun 30, 2026.
Financials
DexCom reported revenue of $4.66B for fiscal 2025, up 15.60% from fiscal 2024.
DexCom earned net income of $836.30M in fiscal 2025, a net margin of 17.9%.
Fiscal 2025 revenue was the highest in the 10 years shown.
Annual revenue
| Fiscal year | Revenue | Growth | Net income | Net margin | EPS (diluted) | Free cash flow |
|---|---|---|---|---|---|---|
| FY2025ended Dec 31, 2025 | $4.66B | +15.6% | $836.30M | 17.9% | $2.09 | $1.08B |
| FY2024ended Dec 31, 2024 | $4.03B | +11.3% | $576.20M | 14.3% | $1.42 | $630.70M |
| FY2023ended Dec 31, 2023 | $3.62B | +24.5% | $541.50M | 15.0% | $1.30 | $511.90M |
| FY2022ended Dec 31, 2022 | $2.91B | +18.8% | $341.20M | 11.7% | $0.82 | $304.70M |
| FY2021ended Dec 31, 2021 | $2.45B | +27.1% | $216.90M | 8.9% | $0.53 | $53.30M |
| FY2020ended Dec 31, 2020 | $1.93B | +30.5% | $549.70M | 28.5% | $0.3325 | $276.60M |
| FY2019ended Dec 31, 2019 | $1.48B | +43.1% | $101.10M | 6.9% | $0.275 | $134.50M |
| FY2018ended Dec 31, 2018 | $1.03B | +43.6% | −$127.10M | −12.3% | −$0.36 | $56.10M |
| FY2017ended Dec 31, 2017 | $718.50M | +25.3% | −$50.20M | −7.0% | −$0.145 | $26.00M |
| FY2016ended Dec 31, 2016 | $573.30M | — | −$65.60M | −11.4% | −$0.195 | $500.00K |
| Quarter | Revenue | Net income | EPS (diluted) |
|---|---|---|---|
| Q2 FY2026ended Jun 30, 2026 | $1.31B | $249.10M | $0.64 |
| Q1 FY2026ended Mar 31, 2026 | $1.19B | $199.50M | $0.51 |
| Q4 FY2025ended Dec 31, 2025 | $1.26B | $267.30M | $0.67 |
| Q3 FY2025ended Sep 30, 2025 | $1.21B | $283.80M | $0.70 |
| Q2 FY2025ended Jun 30, 2025 | $1.16B | $179.80M | $0.45 |
| Q1 FY2025ended Mar 31, 2025 | $1.04B | $105.40M | $0.27 |
| Q4 FY2024ended Dec 31, 2024 | $1.11B | $151.70M | $0.37 |
| Q3 FY2024ended Sep 30, 2024 | $994.20M | $134.60M | $0.34 |
Company profile
- Name
- DexCom, Inc.
- Ticker
- DXCM
- Exchange
- NASDAQ
- Industry (SEC SIC)
- Surgical & Medical Instruments & Apparatus
- Headquarters
- 6340 Sequence Drive, San Diego, CA 92121
- Incorporated in
- DE
- Fiscal year ends
- December
- SEC CIK
- 0001093557
Recent SEC filings
- Sep 14, 2026
- Sep 10, 2026
- Jul 30, 2026
- Jul 30, 2026
- May 28, 2026
- May 15, 2026
- Apr 30, 2026
- Apr 30, 2026
Frequently asked questions
What is DexCom's stock price?
DexCom (DXCM) closed at $626.14 on Oct 9, 2026, up 0.08% from the previous close of $625.67.
What is DexCom's market cap?
DexCom's market cap is $236.31B, based on a share price of $626.14 and 377.4M shares outstanding as of Jun 30, 2026.
How much revenue does DexCom make?
DexCom reported revenue of $4.66B for fiscal 2025, up 15.60% from fiscal 2024.
What is DXCM's P/E ratio?
DexCom's price-to-earnings ratio is 248.5, based on trailing twelve-month diluted EPS of $2.52.
Does DexCom pay a dividend?
DexCom's recent filings report no dividends declared over the last four quarters.
Sources and methodology
Fundamentals come from DexCom, Inc.'s filings with the SEC (EDGAR XBRL company facts). Fourth-quarter figures that companies don't report separately are calculated as the fiscal year minus the first three quarters. Trailing twelve-month (TTM) figures sum the latest four quarters. Prices are generated sample data for development. Last updated Oct 9, 2026. Data sources and disclosures